Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Uscom

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Uscom2
  • Echocardiography1

Active Sponsors

  • Icahn School of Medicine at Mount Sinai1
  • Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital1

Top Investigators

Related Conditions

  • Echocardiography1
  • Fetal Growth Restriction1
  • Echocardiography Guided Fluid Management1

Activity Timeline